206 related articles for article (PubMed ID: 7166751)
1. Influence of Bestatin, a new immunomodulator, on various functions of human monocytes.
Jarstrand C; Blomgren H
J Clin Lab Immunol; 1982 Dec; 9(3):193-8. PubMed ID: 7166751
[TBL] [Abstract][Full Text] [Related]
2. Bestatin, a new immunomodulator, enhances migration and phagocytosis of human granulocytes in vitro.
Jarstrand C; Blomgren H
J Clin Lab Immunol; 1981 Jan; 5(1):67-9. PubMed ID: 7012355
[TBL] [Abstract][Full Text] [Related]
3. Increased granulocyte phagocytosis after oral administration of bestatin, a new immunomodulator.
Jarstrand C; Blomgren H
J Clin Lab Immunol; 1982 Feb; 7(2):115-8. PubMed ID: 7069782
[No Abstract] [Full Text] [Related]
4. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
5. Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study.
Blomgren H; Strender LE; Edsmyr F
Biomedicine; 1980 Dec; 32(4):178-85. PubMed ID: 7470579
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man.
Nathanson SD; Zamfirescu PL; Portaro JK; deKernion JB; Fahey JL
J Natl Cancer Inst; 1978 Aug; 61(2):301-6. PubMed ID: 355647
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood monocyte function in leprosy patients.
Masuda A; Scheinberg MA
Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):254-9. PubMed ID: 7192267
[TBL] [Abstract][Full Text] [Related]
8. Bestatin, a new immunomodulator, augments the release of mitogenic factors from PHA-stimulated human lymphocytes.
Blomgren H
Biomedicine; 1981 Dec; 34(4):188-92. PubMed ID: 6979352
[TBL] [Abstract][Full Text] [Related]
9. Defective monocyte chemotaxis in pulmonary tuberculosis.
Nielsen H; Bennedsen J; Larsen SO; Rhodes JM; Viskum K
Eur J Respir Dis; 1982 Mar; 63(2):122-9. PubMed ID: 7067763
[TBL] [Abstract][Full Text] [Related]
10. [Experimental and clinical studies of bestatin as an immunomodulator].
Miwa H; Oka T; Tsurumi T; Sakae Y; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1019-24. PubMed ID: 7184437
[TBL] [Abstract][Full Text] [Related]
11. Bestatin-induced enhancement of in vivo phagocytosis determined by a new simple assay.
Peschke T; Recknagel RD; Veckenstedt A; Baumgart J; Werner W
Allerg Immunol (Leipz); 1991; 37(3-4):125-9. PubMed ID: 1793085
[TBL] [Abstract][Full Text] [Related]
12. Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial.
Blomgren H; Edsmyr F; Esposti PL; Näslund I
Biomed Pharmacother; 1984; 38(3):143-9. PubMed ID: 6383491
[TBL] [Abstract][Full Text] [Related]
13. Influence of human plasma high density lipoproteins from septic patients on different functions of normal human neutrophils.
Jarstrand C; Holmquist L; Wiernik A; Akerlund B; Carlson LA
J Clin Lab Immunol; 1990 Oct; 33(2):69-73. PubMed ID: 1967068
[TBL] [Abstract][Full Text] [Related]
14. Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation.
Ino K; Bierman PJ; Varney ML; Heimann DG; Kuszynski CA; Walker SA; Talmadge JE
Cancer Immunol Immunother; 1996 Dec; 43(4):206-12. PubMed ID: 9003465
[TBL] [Abstract][Full Text] [Related]
15. Effect of autologous and homologous serum and circulating immune complexes on monocyte functions of patients with solid tumours.
Celada A; Aguado T; Lambert PH; Cruchaud A
Clin Exp Immunol; 1980 Aug; 41(2):326-35. PubMed ID: 7438558
[TBL] [Abstract][Full Text] [Related]
16. Diazepam inhibits phagocytosis and killing exerted by polymorphonuclear cells and monocytes from healthy donors. In vitro studies.
Covelli V; Decandia P; Altamura M; Jirillo E
Immunopharmacol Immunotoxicol; 1989; 11(4):701-14. PubMed ID: 2628482
[TBL] [Abstract][Full Text] [Related]
17. [Study of the ability of monocytes from patients with pulmonary tuberculosis to reduce nitroblue tetrazolium during phagocytosis of latex particles].
Shatrov VA; Kuznetsova LV; Belianovskaia TI
Lab Delo; 1985; (7):408-10. PubMed ID: 2414520
[No Abstract] [Full Text] [Related]
18. Immunopotentiation in infectious disease, I. Effect of bestatin on the immune response.
Ormrod DJ; Cawley S; Miller TE
Chemioterapia; 1985 Aug; 4(4):313-23. PubMed ID: 3876888
[TBL] [Abstract][Full Text] [Related]
19. [An assessment of the bactericidal capacity of the blood monocytes in tuberculosis patients].
Mel'nikov VP
Probl Tuberk; 1993; (1):45-7. PubMed ID: 8327440
[TBL] [Abstract][Full Text] [Related]
20. Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages.
Lkhagvaa B; Tani K; Sato K; Toyoda Y; Suzuka C; Sone S
Cytokine; 2008 Dec; 44(3):386-91. PubMed ID: 19036603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]